Listen to Pharma and BioTech Daily podcast

Summit & Akeso's Ivonescimab Beats Keytruda in NSCLC Phase 3 \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:26
AstraZeneca & Roche Secure EU Breast Cancer Approval \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:59
Novartis' Rhapsido Hits Phase 3 Goals for MS \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:15
Eli Lilly Acquires Merida for $2.9B \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:47
Eli Lilly's $173M FDA Win: Mounjaro Approved! \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:30
Revolution Medicines' $2.25B FDA Approval Milestone \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:53
Revolution Medicines FDA Win: RAS Inhibitor Approved \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:13
FDA Extends Capricor Review: $2.25B McKesson Deal \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:14
Roche & Hanmi's $2.5B Obesity Drug Deal \| Pharma and Biotech Daily	Pharma and BioTech Daily	08:38
Roche's $750M Genentech Expansion Boosts Biologics \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:35
Ultragenyx's $97M Gene Therapy Breakthrough! \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:00
Merck's $1B Melanoma Vaccine Breakthrough \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:34
Biokin's $275M ADC Success in Phase 3 Trial \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:35
AstraZeneca Tagrisso Breakthrough: Phase 3 Success in NSCLC \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:13
FDA Fast-Tracks NASH Drug \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:46
AstraZeneca's Baxfendy Setback: Pricing Woes \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:55
Akeso's Ivonescimab Wins NSCLC Approval in China \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:29
Bristol Myers Squibb's $2.3B Texas Investment Boosts Jobs \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:07
Novo Nordisk & AWS Partner for AI Drug Discovery Breakthrough \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:13
Replimune's FDA Win: Tudriqev Approved After 2 Rejections \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:27
Moderna mRNA Flu Vaccine Approved by FDA \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:17
Eli Lilly's $23B Q2 Revenue Breaks Records \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:55
Otsuka's Voyxact Shines in Phase 3 Trial \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:47
Supernus & Indivior $2.2B Merger Creates CNS Giant \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:30
Replimune's Breakthrough in Cancer Therapy \| Pharma and Biotech Daily	Pharma and BioTech Daily	06:06
Johnson & Johnson's $785M CAR-T Deal & More \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:49
Biogen Acquires Apellis for Growth \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:00
GlaxoSmithKline's $2.5B Restructuring Near AstraZeneca \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:02
AstraZeneca's $80B Target Amid Setbacks? \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:31
Scribe Therapeutics Raises $129M in IPO \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:20
Eli Lilly's Retatrutide: 22.6% Weight Loss in Phase 3! \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:34
Repligen Buys BioLife for $1.5B \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:06
Bristol Myers & NVIDIA's $1.5B AI Deal: Game Changer? \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:52
Samsung Biologics' $1.8B Peptide Expansion \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:36
Jasper Merges with Kira for $292M \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:19
Merck's $5B Lipfendra FDA Approval Revolutionizes Cholesterol \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:46
Veradermics' $2B Hair Loss Market Move with Oral Minoxidil \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:48
Biogen's $1.5B Deal & FDA Approval for Alzheimer's Drug \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:35
Pfizer & Merck's $3B Bladder Cancer Breakthrough \| Pharma and Biotech Daily	Pharma and BioTech Daily	04:57
Sanofi's FDA Approval: $160M Boost for Sarclisa in Cancer Care \| Pharma and Biotech Daily	Pharma and BioTech Daily	05:16

Summit & Akeso's Ivonescimab Beats Keytruda in NSCLC Phase 3 | Pharma and Biotech Daily

Pharma and BioTech Daily

05:26

AstraZeneca & Roche Secure EU Breast Cancer Approval | Pharma and Biotech Daily

Pharma and BioTech Daily

04:59

Novartis' Rhapsido Hits Phase 3 Goals for MS | Pharma and Biotech Daily

Pharma and BioTech Daily

05:15

Eli Lilly Acquires Merida for $2.9B | Pharma and Biotech Daily

Pharma and BioTech Daily

04:47